Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia

References

• PaulSMPurdyRHNeuroactive SteroidsFASEB J19926231123221347506
   PubMed Web of Science ®Google Scholar
• ManingerNWolkowitzOMReusVIEpelESMellonSHNeurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)Front Neuroendocrinol200930659119063914
   PubMed Web of Science ®Google Scholar
• RitsnerMMaayanRGibelAStrousRDModaiIWeizmanAElevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patientsEur Neuropsychopharmacol20041426727315163435
   PubMed Web of Science ®Google Scholar
• LererBRanABlackerMNeuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunctionSchizophr Res198814054103154528
   PubMed Web of Science ®Google Scholar
• MeltzerHYLeeMAJayathilakeKThe blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophreniaNeuropsychopharmacology20012427829011166518
   PubMed Web of Science ®Google Scholar
• BaulieuEERobelPDehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive steroidsJ Endocrinol1996150221239
   Web of Science ®Google Scholar
• WolfOTNeumannOHellhammerDHEffects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and menJ Clin Endocrinol Metab199782236323679215320
   PubMed Web of Science ®Google Scholar
• RupprechtRdi MichelleFHermannBNeuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacologyBrain Res Brain Res Rev200137596711744074
   PubMedGoogle Scholar
• RitsnerMSPregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trialsCNS Neurosci Ther201016324420070787
   PubMed Web of Science ®Google Scholar
• AlexanderGMPetersonBSSex steroids and human behavior: implications for developmental psychopathologyCNS Spectr20016758817008833
   PubMedGoogle Scholar
• WalderDJWalkerEFLewineRJCognitive functioning, cortisol release, and symptom severity in patients with schizophreniaBiol Psychiatry2000481121113211137052
   PubMed Web of Science ®Google Scholar
• BrophyMHRushJACrowleyGCortisol, estradiol, and androgens in acutely ill paranoid schizophrenicsBiol Psychiatry1983185835906222771
   PubMed Web of Science ®Google Scholar
• OadesRDSchepkerRSerum gonadal steroid hormones in young schizophrenic patientsPsychoneuroimmunology199419373385
   PubMed Web of Science ®Google Scholar
• StrousRDMaayanRLapidusRIncreased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatologySchizophr Res20047142743415474914
   PubMed Web of Science ®Google Scholar
• StrousRDMaayanRKaminskyMBlumensohnRWeizmanASpivakBDHEA and DHEA-S levels in hospitalized adolescents with first-episode schizophrenia and conduct disorder: a comparison studyEur Neuropsychopharmacol20091949950319351578
   PubMed Web of Science ®Google Scholar
• YıldırımODoganOSemizMKilicliFSerum cortisol and dehydroepiandrosterone-sulfate levels in schizophrenic patients and their first-degree relativesPsychiatry Clin Neurosci20116558459121895860
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashingtonAmerican Psychiatric Association2000
   Google Scholar
• AndreasenNCScale for the Assessment of Negative Symptoms (SANS)Iowa CityCollege of Medicine, University of Iowa1984
   Google Scholar
• AndreasenNCScale for the Assessment of Positive Symptoms (SAPS)Iowa CityCollege of Medicine, University of Iowa1984
   Google Scholar
• FirstMBSpitzerRLGibbonMWilliamsJBStructured Clinical Interview for DSM-IV Axis I Disorders (SCID-I): Clinician VersionWashingtonAmerican Psychiatric Press1996
   Google Scholar
• CorapciogluAAydemirOYildizMStructured clinical interview for DSM-IV (SCID-IV): Turkish version]AnkaraHekimler Yayin Birligi1999 Turkish
   Google Scholar
• ErkoçSArkonaçOAtaklıCOzmenENegatif semptomları değerlendirme ölçeğinin güvenirliği ve geçerliliği. [The reliability and validity of scale for the assessment of negative symptoms.]Düşünen Adam199141619
   Google Scholar
• ErkoçSArkonaçOAtaklıCOzmenEPozitif semptomları değerlendirme ölçeğinin güvenirlirliği ve geçerliliği. [The reliability and validity of scale for the assessment of positive symptoms.]Düşünen Adam199142024
   Google Scholar
• BilderRMNeurocognitive impairment in schizophrenia and how it affects treatment optionsCan J Psychiatry1997422552649114941
   PubMed Web of Science ®Google Scholar
• TourneyGErbJLTemporal variations in androgens and stress hormones in control and schizophrenic subjectsBiol Psychiatry197914395404157785
   PubMed Web of Science ®Google Scholar
• GoyalROSagarRAmminiACKhuranaMLAliasAGNegative correlation between negative symptoms of schizophrenia and testosterone levelsAnn N Y Acad Sci2004103229129415677432
   PubMed Web of Science ®Google Scholar
• YilmazNHerkenHCicekHKCelikAYurekliMAkyolOIncreased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophreniaMed Princ Pract20071613714117303950
   PubMed Web of Science ®Google Scholar
• MaayanRYagorowskiYGrupperDBasal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatientsBiol Psychiatry20004869370111032981
   PubMed Web of Science ®Google Scholar
• KaasikASafiulinaDKaldaAZharkovskyADehydroepiandrosterone sulphate prevents oxygen-glucose deprivation-induced injury in cerebellar granule cell cultureNeuroscience200110242743211166128
   PubMed Web of Science ®Google Scholar
• KimonidesVGKhatibiNHSvendsenCNSofroniewMVHerbertJDehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) protect hippocampal neurons against excitatory amino acid-induced neurotoxicityProc Natl Acad Sci U S A199895185218579465106
   PubMed Web of Science ®Google Scholar
• ZhangLLiBMaWDehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signalling pathway in opposing waysBrain Res Mol Brain Res200298586611834296
   PubMedGoogle Scholar
• RosenfeldRSRosenbergBJFukushimaDKHellmanL24-Hour secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfateClin Endocrinol Metab197540850855
   Google Scholar
• CorpéchotCRobelPAxelsonMSjövallJBaulieuEECharacterization and measurement of dehydroepiandrosterone sulfate in rat brainProc Natl Acad Sci U S A198178470447076458035
   PubMed Web of Science ®Google Scholar
• OberbeckRBenschopRJJacobsREndocrine mechanisms of stress-induced DHEA secretionJ Endocrinol Invest1998211481539591209
   PubMed Web of Science ®Google Scholar
• SöndergaardHPHanssonLOTheorellTElevated blood levels of dehydroepiandrosterone sulphate vary with symptom load in posttraumatic stress disorder: findings from a longitudinal study of refugees in SwedenPsychother Psychosom20027129830312207110
   PubMed Web of Science ®Google Scholar
• SpivakBMaayanRKotlerMElevated circulatory levels of GABA(A)-antagonistic neurosteroids in patients with combat-related post-traumatic stress disorderPsychol Med2000301227123112027057
   PubMed Web of Science ®Google Scholar
• ShirayamaYHashimotoKSuzukiYHiguchiTCorrelation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophreniaSchizophr Res200258697412363392
   PubMed Web of Science ®Google Scholar
• MarxCELiebermanJAPsychoneuroendocrinology of schizophreniaPsychiatr Clin North Am1988214134349670234
   PubMed Web of Science ®Google Scholar
• WalkerEFDiforioDSchizophrenia: a neural diathesis-stress modelPsychol Rev19971046676859337628
   PubMed Web of Science ®Google Scholar
• OrentreichNBrindJLVogelmanJHAndresRBaldwinHLong term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal menJ Clin Endocrinol Metab199275100210041400863
   PubMed Web of Science ®Google Scholar
• ChanaGBousmanCAMoneyTTBiomarker investigations related to pathophysiological pathways in schizophrenia and psychosisFront Cell Neurosci201379523805071
   PubMed Web of Science ®Google Scholar
• HimmerichHSchönherrJFuldaSSheldrickAJBauerKSackUImpact of antipsychotics on cytokine production in-vitroJ Psychiatr Res2011451358136521592521
   PubMed Web of Science ®Google Scholar
• BorovcaninMJovanovicIRadosavljevicGElevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapseJ Psychiatr Res2012461421142622974591
   PubMed Web of Science ®Google Scholar
• SchmidtLCeglarekUKortzLMechanisms of involvement of eicosanoids and their precursors in the pathophysiology and treatment of schizophreniaMed Chem2013976377323590232
   PubMed Web of Science ®Google Scholar